The Board of Directors of BNP Paribas met on 2 May 2022. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2022.

We have been made aware of recent efforts by unauthorised third parties attempting to impersonate BNP Paribas websites for fraudulent purposes, such as requesting a bank transfer. It is important to note that the official address of our Japan website…

The Board of Directors of BNP Paribas met on 7 February 2022, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter 2021 and endorsed the 2021 financial statements.

The Board of Directors of BNP Paribas met on 28 October 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the third quarter 2021.

On the strength of its confirmed growth potential and solid balance sheet and performances, BNP Paribas announces today the launch of a share buyback program of BNP Paribas S.A. ordinary shares for a maximum total amount of €900 million. BNP…

BNP Paribas Group in Japan has joined a heartfelt “Hospital Art” project in partnership with Kei Tanaka, Associate Professor at Tokushima University and artist, Koichi Nishimura, known for his artwork made with masking tapes.

The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.

BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for

The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.

After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.